Detection of autoimmunity by pharmaceuticals

Methods

Volumn 41, Issue 1, 2007, Pages 112-117

  Pieters, Raymond ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Autoimmunity; Pharmaceuticals; PLNA; Predictive models

Indexed keywords

ANTIGEN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; AUTOANTIGEN; CAPTOPRIL; DICLOFENAC; FELBAMATE; FICOLL; GOLD SALT; HEXACHLOROBENZENE; IMMUNOGLOBULIN E; MERCURY CHLORIDE; NEVIRAPINE; OVALBUMIN; PENICILLAMINE; PHENYTOIN; PICRIC ACID; PROCAINAMIDE; QUINIDINE;

ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; DRUG ERUPTION; DRUG EXPOSURE; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG TOLERABILITY; EXPERIMENTAL MODEL; GENETIC PREDISPOSITION; GLOMERULONEPHRITIS; HYPERIMMUNOGLOBULINEMIA; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOLOGICAL PARAMETERS; IMMUNOTOXICITY; INNATE IMMUNITY; LOW DRUG DOSE; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; NONHUMAN; POPLITEAL LYMPH NODE ASSAY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; SENSITIZATION; SINGLE DRUG DOSE; SPLENOMEGALY; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; DISEASE MODELS, ANIMAL; DRUG TOXICITY; LOCAL LYMPH NODE ASSAY; RATS; RATS, INBRED BN;

ANIMALIA;

EID: 33845218187     PISSN: 10462023     EISSN: 10959130     Source Type: Journal    
DOI: 10.1016/j.ymeth.2006.09.005     Document Type: Article

References (48)

1. Adkinson Jr. N.F., Essayan D., Gruchalla R., Haggerty H., Kawabata T., Sandler J.D., Updyke L., Shear N.H., and Wierda D. J. Allergy Clin. Immunol. 109 (2002) s461-s478
2. D'Cruz D. Toxicol. Lett. 112-113 (2000) 421-432
3. Michielsen C.C., van Loveren H., and Vos J.G. Environ. Health Perspect. 107 Suppl. 5 (1999) 783-792
4. Ezendam J., Vos J., and Pieters R. J. Immunotoxicol. 1 (2004) 167-175
5. Powell J.J., Van de Water J., and Gershwin M.E. Environ. Health Perspect. 107 Suppl. 5 (1999) 667-672
6. Shenton J.M., Chen J., and Uetrecht J.P. Chem. Biol. Interact. 150 (2004) 53-70
7. Gruchalla R.S. J. Allergy Clin. Immunol. 108 (2001) 475-488
8. Pichler W.J. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 249-253
9. Olsen N.J. Best Pract. Res. Clin. Rheumatol. 18 (2004) 677-688
10. Primeau M.N., and Adkinson Jr. N.F. Curr. Opin. Allergy Clin. Immunol. 1 (2001) 337-341
11. Kubicka-Muranyi M., Kremer J., Rottmann N., Lubben B., Albers R., Bloksma N., Luhrmann R., and Gleichmann E. Int. Arch. Allergy Immunol. 109 (1996) 11-20
12. Uetrecht J.P. Chem. Res. Toxicol. 12 (1999) 387-395
13. Matzinger P. Science 296 (2002) 301-305
14. Bach J.F. Nat. Rev. Immunol. 3 (2003) 189-198
15. Bluestone J.A., and Abbas A.K. Nat. Rev. Immunol. 3 (2003) 253-257
16. Weltzien H.U., Moulon C., Martin S., Padovan E., Hartmann U., and Kohler J. Toxicology 107 (1996) 141-151
17. Pichler W.J. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 301-305
18. Masson M.J., and Uetrecht J.P. Chem. Res. Toxicol. 17 (2004) 82-94
19. Nierkens S., and Pieters R. Curr. Opin. Allergy Clin. Immunol. 5 (2005) 331-335
20. Pieters R., and Albers R. Methods 19 (1999) 71-77
21. Ravel G., and Descotes J. J. Appl. Toxicol. 25 (2005) 451-458
22. Albers R., Broeders A., van der Pijl A., Seinen W., and Pieters R. R. Toxicol. Appl. Pharmacol. 143 (1997) 102-109
23. Ezendam J., Staedtler F., Pennings J., Vandebriel R.J., Pieters R., Boffetta P., Harleman J.H., and Vos J.G. Environ. Health Perspect. 112 (2004) 782-791
24. Gutting B.W., Schomaker S.J., Kaplan A.H., and Amacher D.E. Toxicol. Sci. 51 (1999) 71-79
25. Popovic M., Nierkens S., Pieters R., and Uetrecht J. Chem. Res. Toxicol. 17 (2004) 1568-1576
26. Patriarca C., Verdier F., Brouland J.P., and Descotes J. Toxicol. Lett. 66 (1993) 21-28
27. Katsutani N., and Shionoya H. Int. J. Immunopharmacol. 14 (1992) 681-686
28. Albers R., de Heer C., Bol M., Bleumink R., Seinen W., and Pieters R. Eur. J. Immunol. 28 (1998) 1233-1242
29. Nierkens S., van Helden P., Bol M., Bleumink R., van Kooten P., Ramdien-Murli S., Boon L., and Pieters R. J. Immunol. 168 (2002) 3747-3754
30. Albers R., van der Pijl A., Bol M., Bleumink R., Seinen W., and Pieters R. Toxicol. Appl. Pharmacol. 160 (1999) 156-162
31. Weaver J., Chapdelaine J., Descotes J., Germolic D., Holsapple M., House R., Lebrec H., Meade J., Pieters R., Hastings K., and Dean J.J. J. Immunotox. 2 (2005) 11-20
32. Nierkens S., Nieuwenhuijsen L., Thomas M., and Pieters R. Toxicol. Sci. 79 (2004) 90-97
33. Faria A.M., and Weiner H.L. Immunol. Rev. 206 (2005) 232-259
34. Monestier M., Novick K.E., and Losman M.J. Eur. J. Immunol. 24 (1994) 723-730
35. Layland L.E., Wulferink M., Dierkes S., and Gleichmann E. Eur. J. Immunol. 34 (2004) 36-46
36. Bloksma N., de Bakker J.M., van Rooijen H.J., Punt P., Seinen W., and Kammuller M.E. Int. J. Immunopharmacol. 16 (1994) 261-268
37. Robinson C.J., Balazs T., and Egorov I.K. Toxicol. Appl. Pharmacol. 86 (1986) 159-169
38. Nierkens S., Aalbers M., Bol M., van Wijk F., Hassing I., and Pieters R. Toxicol. Sci. 83 (2005) 273-281
39. Gutting B.W., Updyke L.W., and Amacher D.E. Toxicology 172 (2002) 217-230
40. Hirsch F., Kuhn J., Ventura M., Vial M.C., Fournie G., and Druet P. J. Immunol. 136 (1986) 3272-3276
41. Hirsch F., Couderc J., Sapin C., Fournie G., and Druet P. Eur. J. Immunol. 12 (1982) 620-625
42. Balazs T. Toxicol. Ind. Health 3 (1987) 331-336
43. Tournade H., Guery J.C., Pasquier R., Nochy D., Hinglais N., Guilbert B., Druet P., and Pelletier L. Nephrol. Dial. Transplant 6 (1991) 621-630
44. Shenton J.M., Teranishi M., Abu-Asab M.S., Yager J.A., and Uetrecht J.P. Chem. Res. Toxicol. 16 (2003) 1078-1089
45. Donker A.J., Venuto R.C., Vladutiu A.O., Brentjens J.R., and Andres G.A. Clin. Immunol. Immunopathol. 30 (1984) 142-155
46. Shenton J.M., Popovic M., Chen J., Masson M.J., and Uetrecht J.P. Chem. Res. Toxicol. 18 (2005) 1799-1813
47. Sayeh E., and Uetrecht J.P. Toxicol. 163 (2001) 195-211
48. Abedi-Valugerdi M., Nilsson C., Zargari A., Gharibdoost F., DePierre J.W., and Hassan M. Clin. Exp. Immunol. 141 (2005) 238-247